Biotechnology Company Announces Impressive Research At Major Conference

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotechnology firm dedicated to the discovery and development of novel psychedelic-derived therapeutics, has announced its participation in the forthcoming Psychedelic Medicine – Israel 2024 conference. This event will be held in Tel Aviv, Israel, from July 28th to 30th. Uniting leading experts and researchers in the field of psychedelic medicine from around the globe. $Clearmind Medicine(CMND.US)$